Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Outcome

Avience Biomedicals Board Meeting Outcome

Avience Biomedicals approved its audited standalone and consolidated financial results for FY26. The board also noted non-applicability of certain SEBI corporate governance and fund utilization disclosures.

Source

NSE filing, NSE: AVIENCE. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Avience Biomedicals Ltd: key numbers

Share price
₹264.95
Market cap
₹145.3 Cr
Revenue (annual)
₹52.51 Cr
Net profit (annual)
₹8.75 Cr
P/E (TTM)
16.6×Sector 52.3×
Promoter holding
64.59%
FII holding
0.03%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Avience Biomedicals Ltd

All →

Other board meeting outcome announcements

All →